H.R. 1432 - Preserve Access to Affordable Generics Act

Preserve Access to Affordable Generics Act

H.R. 1432 — 110^th Congress (2007–2008)

Summary

To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. (by CRS)

Learn More

at OpenCongress

Title

To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.

Other Titles

• Preserve Access to Affordable Generics Act

Sponsor

Henry Waxman

Co-Sponsors

• Christopher Van Hollen

Subjects

• Business
• Antitrust law
• Competition
• Drug industry
• Generic drugs
• Intellectual property
• Marketing
• Medical care
• Medicine
• Patent infringement
• Pharmaceutical research
• Restrictive trade practices
• Science policy

Related Bills

• S. 316 (110^th) : Preserve Access to Affordable Generics Act

Major Actions

Introduced	3/09/2007
Referred to Committee

Bill History

• All Votes
• All Actions
• Amendments

There have been no votes on this bill.

	Action	Date	Description
	Introduced	3/09/2007
		3/09/2007	Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
		3/09/2007	Referred to House Energy and Commerce
		3/09/2007	Referred to House Judiciary
		3/12/2007	Referred to the Subcommittee on Commerce, Trade and Consumer Protection.

	Number	Sponsor	Date Offered	Status